IGF1R and cancer: The involvement of the IGF-1R pathway and the potential role of miRNAs in cancer therapy prompted us to seek out dysregulating miRNAs that could be involved in the insulin/IGF-1R signaling pathway, as these miRNAs may represent potential PDAC therapeutic targets.